Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ezutromid (BMN 195) is a translation modulator of Small utrophin (EC50: 0.4 uM). Ezutromid is an orally bioavailable small molecule that transcriptionally upregulates the utrophin gene, increasing both utrophin mRNA and protein. Through this action, Ezutromid increases muscle function in dystrophin-deficient MDX mice, a mouse model of muscular dystrophy.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $30 | In Stock | |
5 mg | $48 | In Stock | |
10 mg | $77 | In Stock | |
25 mg | $158 | In Stock | |
50 mg | $253 | In Stock | |
100 mg | $407 | In Stock | |
200 mg | $566 | In Stock | |
1 mL x 10 mM (in DMSO) | $53 | In Stock |
Description | Ezutromid (BMN 195) is a translation modulator of Small utrophin (EC50: 0.4 uM). Ezutromid is an orally bioavailable small molecule that transcriptionally upregulates the utrophin gene, increasing both utrophin mRNA and protein. Through this action, Ezutromid increases muscle function in dystrophin-deficient MDX mice, a mouse model of muscular dystrophy. |
Targets&IC50 | Small utrophin:0.4 μM |
Alias | VOX-C1100, SMT C1100, BMN 195 |
Molecular Weight | 337.39 |
Formula | C19H15NO3S |
Cas No. | 945531-77-1 |
Smiles | S(CC)(=O)(=O)C=1C=C2N=C(OC2=CC1)C3=CC4=C(C=C3)C=CC=C4 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 12 mg/mL (35.57 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.